IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,957,656 | -28.0% | 3,287,397 | +11.4% | 3.99% | -4.5% |
| Q2 2023 | $20,768,831 | +30.0% | 2,950,118 | +12.8% | 4.18% | +0.7% |
| Q1 2023 | $15,977,509 | +16.3% | 2,614,977 | +21.7% | 4.15% | +16.5% |
| Q4 2022 | $13,735,625 | -15.7% | 2,149,550 | +26.4% | 3.56% | -7.6% |
| Q3 2022 | $16,286,000 | +22.9% | 1,700,000 | +41.7% | 3.86% | +4.8% |
| Q2 2022 | $13,248,000 | – | 1,200,000 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |